Brooklyn Roasting Company Pulls Over 3,000 Gallons of Cold Brew Over Botulism Fears
Cold brew coffee has become as much a part of the American morning routine as the alarm clock — smooth, low-acid, and brutally caffeinated. But a major recall out of New York is now forcing wholesale buyers, café operators, and anyone who filled up a pitcher from a bag-in-box concentrate to pay close attention. More than 3,000 gallons of Brooklyn Roasting Company's Pasteurized Cold Brew Concentrate have been voluntarily recalled after concerns that improper storage could lead to the formation of the toxin that causes botulism, a rare but potentially life-threatening illness. This isn't a minor label error or a bureaucratic technicality — it involves one of the deadliest biological toxins known to science, and the circumstances that allowed the risk to develop say something important about how cold brew is made, stored, and sold at scale.
What Was Recalled and Who Is Affected
Brooklyn Roasting Company describes itself as "New York's leading homegrown coffee roasting company, servicing hundreds of high-end wholesale accounts across the 5 boroughs" of New York City. The company has built its reputation supplying upscale hotels, restaurants, and office accounts throughout the metro area — the kind of operation that prides itself on quality control and craft. That reputation is now under scrutiny following a recall announcement that caught the attention of federal food safety regulators.
An FDA report dated July 21, 2026 indicates that starting July 2, the company withdrew 1,219 units carrying 2.5 gallons each of its Pasteurized Cold Brew Concentrate, totaling an apparent 3,047.5 gallons packed as "bag in a box." To put that in perspective, that's enough cold brew to fill a backyard swimming pool — all of it potentially harboring conditions favorable to one of the most dangerous toxins in the food supply.
The recalled concentrate was distributed in New York and New Jersey between April 1, 2026, and June 20, 2026. It includes products with lot codes ranging from 063026 through 093026 and best-by dates between June 3, 2026, and September 3, 2026. That extended best-by window is a critical detail: because some of these products won't expire until September, they may still be sitting in commercial refrigerators, storerooms, or back-of-house supply shelves right now. If you work in food service in the New York or New Jersey area and you source coffee from Brooklyn Roasting Company, this is the time to pull out those lot codes and verify.
The FDA's Classification of This Recall
The U.S. Food and Drug Administration has identified this recall as a Class II — meaning that consumption of the product can cause temporary or medically reversible adverse health consequences. Class II is the middle tier of FDA recall severity. It doesn't mean the threat is trivial — the agency still treats botulism risk with extraordinary seriousness — but it does signal that regulators do not yet have evidence of confirmed contamination at harmful levels. The precautionary nature of the recall, combined with the zero-illness-reported status as of this writing, places this in a different category from a full-blown outbreak scenario. Still, "precautionary" and "safe to ignore" are not the same thing.
The Science Behind the Scare: Why Cold Brew and Botulism Are a Dangerous Pair
Most people associate botulism with improperly home-canned vegetables — the kind of cautionary tale your grandmother recounted when explaining why she triple-checked her Mason jar seals. But the same set of biological conditions that made nineteenth-century pantries dangerous can recreate themselves inside a modern bag-in-box cold brew concentrate, and the reason comes down to chemistry, oxygen, and temperature.
A U.S. patent application filed in 2024 helps illustrate that Clostridium botulinum is one type of microbe that proliferates in sealed environments without oxygen. The acidity in some coffee may not be enough to head off its formation — and it takes heat to kill it off. Sources suggest room-temperature, air-tight-sealed cold brew can be a space friendly to the toxin. Cold brew concentrate, by its very nature, is produced without heat. The cold-steeping process that gives the drink its signature smoothness and reduced bitterness is also the same process that eliminates the thermal kill step that would neutralize Clostridium botulinum spores. When that concentrate then gets sealed into an oxygen-reduced bag-in-box format — a packaging style common in commercial foodservice because of its convenience and shelf life — and is subsequently stored at room temperature rather than under consistent refrigeration, the conditions become nearly ideal for toxin formation.
It's unclear whether the apparent temperature issue occurred due to the extreme heat in New York City this summer or another cause. New York City experienced a brutal stretch of high temperatures in the summer of 2026, with heat advisories stacking up across the five boroughs. Commercial supply chains — delivery trucks, loading docks, back-of-house storerooms — are not always climate-controlled environments. A bag-in-box that spends a few hours at ambient summer temperatures during transit or sitting on a receiving dock may have been enough to start the clock ticking on toxin formation, even if it looked and smelled perfectly normal.
What Clostridium Botulinum Actually Does to the Body
Clostridium botulinum is a neurotoxin that causes botulism — a life-threatening illness that attacks the nervous system and leads to muscle weakness and even paralysis. The mechanism is insidious: the toxin blocks the nerve signals that tell muscles to contract, working from the head downward through the body. Early symptoms often seem like nothing more than a rough morning — some nausea, maybe a headache — but the progression can be rapid and severe.
According to the Centers for Disease Control and Prevention (CDC), botulism can "weaken muscles used in breathing, which can lead to difficulty breathing and even death." The agency also warns, "You cannot see, smell or taste the toxin that causes botulism," and even a small taste can be deadly. That last point deserves emphasis in the context of a cold brew recall. Unlike spoiled milk or rotten meat, contaminated cold brew will look and taste completely normal. There is no sensory cue that would alert even a careful barista or a conscientious restaurant manager to the presence of the toxin.
Symptoms can begin within hours and may include difficulty swallowing, speaking or breathing, blurred vision, nausea, vomiting, stomach pain, and diarrhea. If these symptoms appear after consuming cold brew from Brooklyn Roasting Company — particularly the bag-in-box wholesale format — anyone affected should treat it as a medical emergency rather than a garden-variety stomach bug.
There are three main types of botulism: foodborne, wound, and infant. The Center for Disease Control recommends immediate medical attention for all forms. In the context of this recall, foodborne botulism is the relevant threat. It develops when a person ingests food that already contains the preformed toxin, rather than one that introduces spores that later produce toxin in the body. That distinction matters medically, but the bottom line for consumers is the same: get to an emergency room without delay if symptoms develop.
Expert Perspective: Why Zero Risk Is the Only Acceptable Standard
The food safety community has a specific word for the acceptable level of botulinum toxin in any product intended for human consumption: zero. Not "trace amounts," not "below the threshold of concern" — zero. Bruno Xavier, PhD, associate director of the Cornell Food Venture Center and an expert on botulism risks, told Inc. that "because botulinum toxin is among the most potent toxins known, the acceptable level of risk is essentially zero, which is why the food industry and regulatory agencies devote so much attention to preventing these events before products ever reach consumers." Xavier added that it is the responsibility of food regulatory agencies to identify and protect the public.
Xavier's framing explains why a voluntary recall with zero reported illnesses still commands serious attention. Botulism events are rare precisely because the food industry has built extensive safeguards against them — pasteurization protocols, pH controls, oxygen management, cold chain requirements. When one of those safeguards appears to have broken down, the appropriate response is not to wait for someone to get sick before acting. Brooklyn Roasting Company's decision to pull the product before a single illness was reported reflects exactly the kind of precautionary posture that food safety experts advocate.
Brooklyn Roasting Company's Response
The Brooklyn Roasting Company told Inc. that it voluntarily ordered the recall and that there have been no illnesses reported. The company characterized the action as precautionary, and it's said the company voluntarily contacted accounts or the public to alert them of the recall via two methods of outreach. That dual-channel notification approach — reaching out directly to wholesale accounts while also engaging with public-facing media channels — is consistent with FDA best practices for Class II recalls affecting products distributed through commercial intermediaries rather than direct-to-consumer retail.
For a company that has built its entire brand around serving high-end wholesale accounts across the New York metro area, the reputational stakes are significant. A café or hotel that served contaminated cold brew to its customers, even if no illness resulted, faces its own liability and credibility questions. The speed of Brooklyn Roasting Company's self-initiated recall — pulling product before regulators demanded it — is the right call, and it's worth noting that kind of proactive corporate behavior even as questions persist about how the storage conditions leading to the risk developed in the first place.
What Consumers and Foodservice Buyers Should Do Right Now
Consumers who have the product are advised not to drink it and should instead throw it away or return it to the place of purchase. For individual consumers, the primary concern is whether any of this cold brew concentrate made it into finished drinks that were served at a restaurant, café, or office — those are the wholesale distribution channels most likely to be affected. If you regularly buy cold brew from a coffee shop in New York or New Jersey, it's worth asking whether they source from Brooklyn Roasting Company and when their most recent delivery occurred.
For foodservice operators, the checklist is straightforward but urgent. Pull any bag-in-box cold brew concentrate from Brooklyn Roasting Company currently in inventory. Check the lot codes: products with lot codes ranging from 063026 through 093026 and best-by dates between June 3, 2026, and September 3, 2026 are the affected units. Do not use the product regardless of whether it appears, smells, or tastes normal. Contact your Brooklyn Roasting Company account representative to initiate a return or refund process, and document the disposal of any product you cannot return.
A Pattern in Cold Brew: This Isn't the First Time
The Brooklyn Roasting Company recall does not exist in a vacuum. The cold brew category has navigated botulism concerns before, and the pattern reveals something structural about the way ready-to-drink and concentrate-format cold coffee products interact with standard food safety frameworks.
In 2017, Death Wish Coffee Company — the upstate New York brand that markets itself on extreme caffeine content — faced a strikingly similar situation. Death Wish Coffee Co. recalled 11-ounce Nitro Cold Brew cans after determining that its manufacturing process could lead to growth of bacteria producing botulin toxin. In that case, the risk was tied to the nitro cold brew canning process, which by design operates in a reduced-oxygen environment — precisely the conditions that Clostridium botulinum favors. Mike Brown, founder of the company, said production of Nitro Cold Brew would be halted until an additional manufacturing process was implemented.
The parallel between the 2017 Death Wish recall and the 2026 Brooklyn Roasting Company action highlights a durable tension in the cold brew market: the same production and packaging techniques that give cold brew its commercial appeal — oxygen-reduced packaging, no-heat processing, long shelf life — are exactly the characteristics that create risk if temperature controls are not maintained throughout the supply chain. Every year that the cold brew category grows, the exposure to this class of risk grows proportionally.
The Broader Food Safety Moment
The cold brew recall lands in a summer already marked by high-profile food safety scares across the consumer food landscape. The cold brew recall is the latest in a string of high-profile food safety alerts this summer. Just days ago, Midwest Poultry Services voluntarily recalled nearly 19 million eggs — about 1.6 million dozen — over potential salmonella enteritidis contamination. The drumbeat of recalls across product categories reflects both a more vigilant regulatory environment and, arguably, the increasing complexity of modern food supply chains that move products across multiple states and through multiple handlers before they reach the end consumer.
For the cold brew market specifically, the recall arrives at an uncomfortable moment. Cold brew has been one of the fastest-growing segments in the entire beverage industry, moving from a niche specialty café product into grocery aisles, office pantry programs, and wholesale foodservice across the country. The bag-in-box format at the center of this recall is particularly popular with restaurants, hotels, and corporate accounts because of its ease of use — tap a spigot, pour over ice, done. That convenience, however, depends on a cold chain that stays cold, and in the middle of a New York summer, that chain has more opportunities to break down than it does in February.
The Bigger Picture: Cold Chain Integrity and the Wholesale Coffee Business
The phrase buried in the FDA recall documentation — "ambient storage of the product may lead to Clostridium botulinum toxin formation" — deserves more scrutiny than it typically receives in the rapid-fire news cycle of a product recall. "Ambient storage" is a technical way of saying room temperature. It means something along the distribution or storage chain, a product that requires refrigeration was left at conditions warm enough to support microbial activity. In a sealed, low-oxygen, liquid food product, that can be enough.
Cold brew concentrate in a bag-in-box format is a perishable product that depends entirely on consistent refrigeration from the moment it leaves the production facility to the moment it's tapped and served. Unlike canned or shelf-stable products that have undergone retort processing at high heat, pasteurized cold brew concentrate does not have the margin for error that a fully commercially sterile product would. Pasteurization reduces the microbial load significantly, but it does not eliminate botulinum spores — only the higher temperatures of retort processing can do that. Once the product leaves the pasteurizer and gets sealed into its bag-in-box, the cold chain becomes the only line of defense.
For wholesale buyers, that means asking harder questions of their suppliers: What are the temperature logs for this delivery? How was this product stored before it arrived on my dock? What is the company's protocol if a delivery truck's refrigeration unit malfunctions in transit? These are questions that good distributors should have ready answers for. The Brooklyn Roasting Company recall is a useful prompt to make sure those conversations are actually happening.
What This Means Going Forward
The cold brew category is not going away. Americans have demonstrated, year over year, that they will pay a premium for quality cold-extracted coffee, and the commercial infrastructure supporting that market — dedicated production facilities, specialized packaging lines, multi-state distribution networks — has grown to match demand. But growth at scale requires that food safety systems scale proportionally.
For Brooklyn Roasting Company, the path forward requires more than just pulling the affected units. It requires a thorough root cause analysis: identifying exactly where in the cold chain the temperature deviation occurred, whether it was an isolated incident or a systemic gap, and what changes to production, packaging, or distribution protocols will prevent a recurrence. Given that Brooklyn's approximately 37 independent coffee roasters trail just behind Portland's 44 and Chicago's 43 — and even ahead of the 26 roasters that call coffee capital Seattle home — the competitive stakes for Brooklyn's craft coffee identity are real. A mishandled recall response could cost the company the wholesale relationships it has spent years building.
For the broader industry, the lesson is familiar even if it keeps needing to be relearned: cold brew's defining production characteristic — the absence of heat — is also its principal food safety vulnerability. Managing that vulnerability requires cold chain discipline that extends not just through the roaster's own facility but through every hand the product passes through before it's poured into a cup. When the summer heat pushes ambient temperatures into territory that Clostridium botulinum finds hospitable, the margin for error shrinks to nothing.
Anyone experiencing symptoms after consuming the recalled product should seek medical attention immediately. No one should have to think about paralysis or breathing difficulties when they reach for their morning coffee — and with the right supply chain practices, they won't have to.
